July 20, 2023
Kyosomirai Pharma and Nihon Generic said on July 19 that their respective generic versions of the cholesterol fighter Crestor (rosuvastatin) have won an additional indication of familial hypercholesterolemia. With the latest approvals, the two companies’ generics now have the full...read more